Water vapour-based medical device developer Aegea Medical has raised $36m from new and existing investors including Covidien/Medtronic.
US-based medical device company Aegea Medical closed a $36m series C round yesterday featuring medical device maker Covidien/Medtronic and biotech real estate company BioMed’s corporate venturing arm, BioMed Ventures.
Venture capital firms Alloy Ventures, Delphi Ventures and Solas Bioventures also took part in the round.
Covidien, which merged with fellow medical device producer Medtronic in January this year, led Aegea’s $13.3m series B round in 2011, after participating in a $2m series A round in 2008 alongside Delphi and Alloy.…
